BRAIN NICOTINE BINDING-SITES

被引：80

作者：

WONNACOTT, S

机构：

来源：

HUMAN TOXICOLOGY | 1987年 / 6卷 / 05期

关键词：

D O I：

10.1177/096032718700600502

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

引用

页码：343 / 353

页数：11

共 97 条

[1]

ABOOD LG, 1979, ARCH INT PHARMACOD T, V237, P213

[2] ISOLATION OF A NICOTINE BINDING-SITE FROM RAT-BRAIN BY AFFINITY-CHROMATOGRAPHY [J].

ABOOD, LG ;

LATHAM, W ;

GRASSI, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (11) :3536-3539

[3] STEREOSPECIFIC NICOTINE-H-3 BINDING TO INTACT AND SOLUBILIZED RAT-BRAIN MEMBRANES AND EVIDENCE FOR ITS NONCHOLINERGIC NATURE [J].

ABOOD, LG ;

REYNOLDS, DT ;

BIDLACK, JM .

LIFE SCIENCES, 1980, 27 (14) :1307-1314

[4] COMPARISON OF THE BINDING OF OPTICALLY PURE (-)-[H-3]NICOTINE AND (+)-[H-3]NICOTINE TO RAT-BRAIN MEMBRANES [J].

ABOOD, LG ;

GRASSI, S ;

NOGGLE, HD .

NEUROCHEMICAL RESEARCH, 1985, 10 (02) :259-267

[5] STUDIES ON THE MECHANISM OF ACTION OF ACETYLCHOLINE ANTAGONISTS ON RAT PARASYMPATHETIC GANGLION-CELLS [J].

ASCHER, P ;

LARGE, WA ;

RANG, HP .

JOURNAL OF PHYSIOLOGY-LONDON, 1979, 295 (OCT) :139-170

[6] THE EFFECTS OF NICOTINE ON BRAIN NEUROTRANSMITTER SYSTEMS [J].

BALFOUR, DJK .

PHARMACOLOGY & THERAPEUTICS, 1982, 16 (02) :269-282

[7] RELATION BETWEEN BIOLOGICAL-ACTIVITY AND DEGREE OF RESOLUTION OF OPTICAL ISOMERS [J].

BARLOW, RB ;

FRANKS, FM ;

PEARSON, JDM .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1972, 24 (10) :753-&

[8] NICOTINE BINDING TO BRAIN-TISSUE FROM DRUG-NAIVE AND NICOTINE-TREATED RATS [J].

BENWELL, MEM ;

BALFOUR, DJK .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (06) :405-409

[9] ISOLATION OF A CDNA CLONE CODING FOR A POSSIBLE NEURAL NICOTINIC ACETYLCHOLINE-RECEPTOR ALPHA-SUBUNIT [J].

BOULTER, J ;

EVANS, K ;

GOLDMAN, D ;

MARTIN, G ;

TRECO, D ;

HEINEMANN, S ;

PATRICK, J .

NATURE, 1986, 319 (6052) :368-374

[10] MEDIATION OF NICOTINE-INDUCED CONVULSIONS BY CENTRAL NICOTINIC RECEPTORS OF THE C6-TYPE [J].

CAULFIELD, MP ;

HIGGINS, GA .

NEUROPHARMACOLOGY, 1983, 22 (03) :347-351

← 1 2 3 4 5 6 7 8 9 10 →